AGAPE ATP
ATPC
5 hedge funds and large institutions have $85.1K invested in AGAPE ATP in 2026 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
67% more funds holding
Funds holding: 3 → 5 (+2)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
6.32% less ownership
Funds ownership: 10.47% → 4.15% (-6.3%)
96% less capital inflows, than outflows
Capital inflows: $8.03K | Capital outflows: $193K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$7.98K |
| 2 |
Caitong International Asset Management
Hong Kong
|
+$5 |
| 3 |
JP Morgan Chase
New York
|
+$2 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HRT Financial
New York
|
-$174K |
| 2 |
Jane Street
New York
|
-$19.1K |
ATPC Hedge Fund Activity: Q3 2026 in Review
5 of the 8,207 institutional investors tracked by Wall St. Rank reported a position in AGAPE ATP (ATPC) for Q3 2026, worth a combined $85.1K — down 73% from $310K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ATPC positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, adding an estimated $7.98K. The largest seller was HRT Financial, exiting entirely with an estimated $174K sold.
- 5 institutional investors held AGAPE ATP (ATPC) as of Q3 2026, up from 3 in Q2 2026.
- Funds reported $85.1K of AGAPE ATP stock for Q3 2026, down 73% quarter-over-quarter.
- 3 funds opened new AGAPE ATP positions in Q3 2026 and 1 closed out, a net change of +2 holders.
- The largest AGAPE ATP buyer in Q3 2026 was UBS Group, an estimated $7.98K added.
- The largest AGAPE ATP seller in Q3 2026 was HRT Financial, an estimated $174K sold.
Based on aggregated 13F filings for Q3 2026.